reference/32847464

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32847464

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	531
issn	1535-7228 0002-953X
issueIdentifier	3
pageRange	529-531
publicationName	The American journal of psychiatry
startingPage	529
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_32645d9afca755984f454c7b1681bb44 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_05dd04cc44d4399ff605476b5576168d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_448f1a74e1dfe865d3ff838b71306cb9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_09ec2b94ac6d593adef89ce8c556cc12
bibliographicCitation	Lencz T, Robinson DG, Xu K, Ekholm J, Sevy S, Gunduz-Bruce H, Woerner MG, Kane JM, Goldman D, Malhotra AK. DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry. 2006 Mar;163(3):529–31. doi: 10.1176/appi.ajp.163.3.529. PMID: 16513877.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3bb2a0201b38735fb792788982a4f2a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fd3304890e9c369ca9f9f816d350d59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d61ab2932921a9ac0c0e7fd1377b5552 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7bb858efabf632b69e62dadb9d2e71c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c40604106909d43f6e40d9eeb8d23a8e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e74732a6a9dd269fdfe646b23c3dbfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56ba986922ff408b638a0c947497e71d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b070e44d3c9f05f500ee9443f954cf9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12d6cf60444ed9d83ac9453f63edd690 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1724-5405 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4dfb0beab77ba75ad17ae83455a3bc95
date	200603
identifier	https://pubmed.ncbi.nlm.nih.gov/16513877 https://doi.org/10.1176/appi.ajp.163.3.529
isPartOf	https://portal.issn.org/resource/ISSN/1535-7228 https://portal.issn.org/resource/ISSN/0002-953X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/457
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients
discusses	http://id.nlm.nih.gov/mesh/M0002356 http://id.nlm.nih.gov/mesh/M0026473 http://id.nlm.nih.gov/mesh/M0028338 http://id.nlm.nih.gov/mesh/M0021770 http://id.nlm.nih.gov/mesh/M0204623
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014644 http://id.nlm.nih.gov/mesh/D011401Q000235 http://id.nlm.nih.gov/mesh/D012559Q000188 http://id.nlm.nih.gov/mesh/D017448Q000235 http://id.nlm.nih.gov/mesh/D012559Q000235 http://id.nlm.nih.gov/mesh/D014150Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D010597 http://id.nlm.nih.gov/mesh/D020022 http://id.nlm.nih.gov/mesh/D012565 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077152 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001569Q000627 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D018967Q000627 http://id.nlm.nih.gov/mesh/D011110 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a20a852de6e0b3ecac342b0499ddb5b

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129101897 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128442098 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235

Total number of triples: 69.